Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Anacor Pharmaceuticals Inc    ANAC   US0324201013

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/30/2015 05/01/2015 05/04/2015 05/05/2015 05/06/2015 Date
52.69(c) 54.4(c) 56.34(c) 55.51(c) 56.34 Last
683 407 752 757 636 833 586 338 53 708 Volume
-5.08% +3.25% +3.57% -1.47% +1.50% Change
More quotes
Financials ($)
Sales 2015 56,5 M
EBIT 2015 -60,6 M
Net income 2015 -67,0 M
Debt 2015 30,0 M
Yield 2015 -
Sales 2016 107 M
EBIT 2016 -24,0 M
Net income 2016 -26,7 M
Debt 2016 30,1 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 44,1x
EV / Sales 2016 23,3x
Capitalization 2 465 M
More Financials
Company
Anacor Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.The company has discovered seven compounds that are currently in development including its lead... 
More about the company
Surperformance© ratings of Anacor Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ANACOR PHARMACEUTICALS INC
05/01 ANACOR PHARMACEUTICALS : to Present at Upcoming Investor Conferences
04/30 ANACOR PHARMACEUTICALS : Announces First Quarter 2015 Financial Results Conferen..
04/16 Leading Small-Cap Stars Health Care Stock for April 16 Morning Session is Eli..
03/18 ANACOR PHARMACEUTICALS : Reports 2014 Fourth Quarter and Year-End Financial Resu..
03/16 ANACOR PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
03/13 QAD : Nasdaq stocks posting largest percentage increases
03/12 ANACOR PHARMACEUTICALS : reports 4Q loss
03/12 ANACOR PHARMACEUTICALS : Results of Operations and Financial Condition, Financia..
More news
Sector news : Biotechnology & Medical Research - NEC
08:36a PUMA BIOTECHNOLOGY : to Present at Bank of America Merrill Lynch Health Care Con..
05/05DJAbbVie Wraps Up Large Debt Sale for Pharmacyclics Deal
05/05DJAbbVie Wraps Up Large Debt Sale For Pharmacyclics Deal
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/05 Notable earnings after Wednesday's close
04/29 INSIDERINSIGHTS.COM DAILY ROUND UP A : Opk, nxrt, cen, utek
04/06 The Best Small Cap Stocks To Buy Now
04/01 Latest Insider Purchases In Abercrombie & Fitch, Anacor Pharmaceuticals And C..
03/24 Anacor Will Surpass Revenue Estimates Again For Q1


Comments 
Advertisement
Chart ANACOR PHARMACEUTICALS INC
Duration : Period :
Anacor Pharmaceuticals Inc Technical Analysis Chart | ANAC | US0324201013 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF